X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q4 2023 Earnings Call Transcript

X4 Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.15.

Keep Reading →